AI offers biopharma companies an unprecedented opportunity to address rising R&D pressures and reimagine how therapies are developed. By accelerating drug discovery, improving clinical success rates and enabling precision therapies, AI could help bring treatments to patients faster, more efficiently and at lower cost.

However, realising AI’s promise requires more than technology alone. Companies must adopt a dual strategy: building strong in-house capabilities while partnering with AI innovators. Effective integration will depend on organisational evolution, clean and connected data systems, and a clear focus on long-term value creation.

Download the full infographic to discover how AI can shape the future of biopharma innovation and precision medicine.

Want to discover more from the L.E.K. Look Forward series? See why 2025 is the year for AI to deliver real and measurable value across all industries.
 

L.E.K. Consulting is a registered trademark of L.E.K. Consulting. All other products and brands mentioned in this document are properties of their respective owners. © 2024 L.E.K. Consulting

Related Insights